Accipiter Capital Management

Latest statistics and disclosures from Accipiter Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are WLP, TEVA, AET, ESRX, CI. These five stock positions account for 79.98% of Accipiter Capital Management's total stock portfolio.
  • Added to shares of GTS (+$10.50M), ARNA.
  • Started new stock positions in GTS, ARNA.
  • Reduced shares in these stocks: HMA (-$25.52M), AET (-$5.40M), ESRX (-$5.07M), HCA HOLDINGS, CI, FVE, TEVA, WLP, CUTR.
  • Sold out of its positions in CUTR, FVE, HCA HOLDINGS, HMA.
  • As of March 31, 2013, Accipiter Capital Management has $96.21M in assets under management (AUM). Assets under management dropped from a total value of $126.41M to $96.21M.
  • Independent of market fluctuations, Accipiter Capital Management was a net seller by $41.67M worth of stocks in the most recent quarter.

Accipiter Capital Management portfolio companies for quarter ending March 2013

Ticker Name Portfolio Weight Change Share Count Price Last Trade
WLP WellPoint 26.99 -5.00% 392122 66.23 77.81
TEVA Teva Pharmaceutical Industries 14.81 -11.00% 359133 39.68 39.99
AET Aetna 14.20 -28.00% 267298 51.13 59.38
ESRX Express Scripts 12.95 -28.00% 216182 57.62 61.24
CI CIGNA Corporation 11.03 -27.00% 170127 62.37 67.80
GTS Triple-S Management 10.92 NEW 602930 17.42 18.45
HPQ Hewlett-Packard Company 8.67 350000 23.84 21.09
ARNA Arena Pharmaceuticals 0.43 NEW 50000 8.22 7.98

Past 13F-HR SEC Filings for Accipiter Capital Management

View All Filings for Accipiter Capital Management